Publication Archive - Epiconcept

Core protocol for ECDC studies of vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection, laboratory-confirmed with SARS-CoV-2 or with seasonal influenza

Liliana Antunes, Jenny Howard, Esther Kissling, Ruoran Li, Alain Moren, Anthony Nardone, Angie Rose, Marta Valenciano

Version 4.0 - 17 Dec 2024

Available here

Primary series COVID-19 vaccine effectiveness among health care workers in the country of Georgia, March–December 2021

Mark A. Katz ,Madelyn Yiseth Rojas Castro ,Giorgi Chakhunashvili,Nazibrola Chitadze,Caleb L. Ward,C. Jason McKnight,Héloïse Lucaccioni,Iris Finci,Tamila Zardiashvili,Richard Pebody,Esther Kissling,Lia Sanodze.

Published: September 6, 2024

Available here

Primary Series and Booster Coronavirus Disease 2019 Vaccine Effectiveness in a Cohort of Healthcare Workers in Albania During a BA.1 and BA.2 Variant Period, January–May 2022

Iris Finci, Madelyn Yiseth Rojas Castro, Iris Hasibra, Jonilda Sulo, Albana Fico, Rovena Daja, Adela Vasili, Majlinda Kota, Iria Preza, Barbara Mühlemann, Christian Drosten, Richard Pebody, Kathryn E Lafond, Esther Kissling, Mark A Katz, Silvia Bino

Open Forum Infectious Diseases, Volume 10, Issue 10, October 2023, ofad479,

Available here

Establishing the African region monitoring vaccine effectiveness (AFRO-MoVE) network for respiratory pathogens

C.E. Gurry, J.M. Mwenda, A. Nardone, S. Cohuet, A. Worwui, M. Valenciano, H.C. Lewis, C.S. Wiysonge, R. Katsande, R. Mukaro, F. Braka, A.S. Gueye, T. Balde, I. Bergeri, B. Impouma

Vaccine 2024, 126616, ISSN 0264-410X

Available here

Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021–May 2023

Savulescu, C., Prats-Uribe, A., Brolin, K., Lovrić Makarić, Z., Uusküla, A., Panagiotakopoulos, G., Bergin, C., Fleming, C., Agodi, A., Bonfanti, P., Murri, R., Zvirbulis, V., Zavadska, D., Szuldrzynski, K., Machado, A., Popescu, C. P., Craiu, M., Cisneros, M., Latorre-Millán, M., … the VEBIS HCW VE Study Group. (2024).

Vaccines, 12(11), 1295.

Available here

Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts, version 3.0

Camelia Savulescu, Esther Kissling, Anthony Nardone (Epiconcept)

Stockholm: ECDC; 2024.

Available here

The Potential Bias Introduced into COVID-19 Vaccine Effectiveness Studies at Primary Care Level Due to the Availability of SARS-CoV-2 Tests in the General Population

Lanièce Delaunay, Charlotte and Nunes, Baltazar and Monge, Susana and de Lange, Marit and Túri, Gergő and Machado, Ausenda and Latorre-Margalef, Neus and Mlinarić, Ivan and Lazar, Mihaela and Botella Rocamora, Paloma and Erdwiens, Annika and Sève, Noémie and Domegan, Lisa and Martínez-Baz, Iván and Hooiveld, Mariëtte and Oroszi, Beatrix and Guiomar, Raquel and Sperk, Maike and Kurečić Filipović, Sanja and Pascu, Catalina and Linares Dopido, Juan Antonio and Dürrwald, Ralf and Rameix-Welti, Marie-Anne and McKenna, Adele and Castilla, Jesús and van Hagen, Cheyenne and Knol, Mirjam J. and Bacci, Sabrina and Kaczmarek, Marlena and Kissling, Esther

Available at SSRN: https://ssrn.com/abstract=5014164

Available here

Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death in eight European countries using electronic health records: first update

Susana Monge Corella, Mario Fontán-Vela (Instituto de Salud Carlos III, Spain), Anthony Nardone, Alexis Sentís, Esther Kissling, James Humphreys Baltazar Nunes (Epiconcept, France), Irina Kislaya, Constantino Caetano, Patricia Soares, Ausenda Machado (Instituto Nacional de Saúde, Portugal), Itziar Casado, Jesús Castilla, Iván Martínez-Baz, Aitziber Echeverria (Instituto de Salud Pública y Laboral de Navarra – IdiSNA – CIBERESP, Spain), Hanne-Dorthe Emborg, Katrin Finderup, Christian Holm Hansen, Bolette Søborg, Palle Valentiner-Branth (Statens Serum Institut, Denmark), Hinta Meijerink, Anja Kristoffersen, Jostein Starrfelt (Norwegian Institute of Public Health), Toon Braeye, Izaak Van Evercooren, Joris Van Loenhout, Pierre Hubin (Epidemiology of infectious diseases, Sciensano, Brussels, Belgium), Ala’a AlKerwi, Susanne Schmitz (Ministry of Health and Social Security, Directorate of Health, Service Epidemiology and Statistics, Luxembourg), Chiara Sacco, Alberto Mateo Urdiales, Massimo Fabiani (Istituto Superiore di Sanità, Italy), Brechje de Gier, Susan Hahné (Dutch National Institute for Public Health and the Environment – RIVM – the Netherlands).

first update. Stockholm: ECDC; 2024.

Available here

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study

Susana Monge, James Humphreys, Nathalie Nicolay, Toon Braeye, Izaak Van Evercooren, Christian Holm Hansen, Hanne-Dorthe Emborg, Chiara Sacco, Alberto Mateo-Urdiales, Jesús Castilla, Iván Martínez-Baz, Brechje de Gier, Susan Hahné, Hinta Meijerink, Anja Bråthen Kristoffersen, Ausenda Machado, Patricia Soares, Anthony Nardone, Sabrina Bacci, Esther Kissling, Baltazar Nunes, VEBIS-EHR Working Group

Available here

Protocol for a COVID-19 vaccine effectiveness multi-country cohort study in the paediatric population aged 5–17-years using electronic health records in EU/EEA countries

Baltazar Nunes, Anthony Nardone, Alexis Sentis, Esther Kissling, James Humphreys

Available here

Publication

Référencement Centrales d'achats

Hébergement de données de santé

Engagement et éthique